Terms: = Breast cancer AND FLI1, SIC-1, 2313, ENSG00000151702, Q01543, EWSR2 AND Treatment
16 results:
1. Fat Body Mass and Vertebral Fracture Progression in Women With breast cancer.
Cosentini D; Pedersini R; Di Mauro P; Zamparini M; Schivardi G; Rinaudo L; Di Meo N; Delbarba A; Cappelli C; Laganà M; Alberti A; Baronchelli M; Guerci G; Laini L; Grisanti S; Simoncini EL; Farina D; Mazziotti G; Berruti A;
JAMA Netw Open; 2024 Jan; 7(1):e2350950. PubMed ID: 38198137
[TBL] [Abstract] [Full Text] [Related]
2. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
[TBL] [Abstract] [Full Text] [Related]
3. Integrative transcriptome analysis of triple negative breast cancer profiles for identification of druggable targets.
Arumugam P; Ramesh V; Sampathkumar B; Perumalsamy H; Balusamy SR; Suganya K; Balraj S; Nachimuthu SK; Sundaravadivelu S
J Biomol Struct Dyn; 2023; 41(21):12106-12119. PubMed ID: 36617953
[TBL] [Abstract] [Full Text] [Related]
4. LINC00092 Modulates Oxidative Stress and Glycolysis of breast cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.
Chen W; Liu Y; Kang S; Lv X; Fu W; Zhang J; Song C
Oxid Med Cell Longev; 2022; 2022():5215748. PubMed ID: 35799892
[TBL] [Abstract] [Full Text] [Related]
5. treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African breast cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study.
Foerster M; McCormack V; Anderson BO; Boucheron P; Zietsman A; Cubasch H; Joffe M; Anele A; Offiah S; Galukande M; Parham G; Pinder LF; Ginsburg O; Schüz J; Dos-Santos-Silva I; Kantelhardt EJ
Lancet Oncol; 2022 Jun; 23(6):729-738. PubMed ID: 35550274
[TBL] [Abstract] [Full Text] [Related]
6. Survival After breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women.
de Boniface J; Szulkin R; Johansson ALV
JAMA Surg; 2021 Jul; 156(7):628-637. PubMed ID: 33950173
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study.
McCormack V; McKenzie F; Foerster M; Zietsman A; Galukande M; Adisa C; Anele A; Parham G; Pinder LF; Cubasch H; Joffe M; Beaney T; Quaresma M; Togawa K; Abedi-Ardekani B; Anderson BO; Schüz J; Dos-Santos-Silva I
Lancet Glob Health; 2020 Sep; 8(9):e1203-e1212. PubMed ID: 32827482
[TBL] [Abstract] [Full Text] [Related]
8. Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
Amelot A; Terrier LM; Cristini J; Buffenoir K; Pascal-Moussellard H; Carpentier A; Bonaccorsi R; Le Nail LR; Mathon B
Eur J Surg Oncol; 2020 Jun; 46(6):1021-1027. PubMed ID: 31899046
[TBL] [Abstract] [Full Text] [Related]
9. Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors.
Tripathy D; Bardia A; Sellers WR
Clin Cancer Res; 2017 Jul; 23(13):3251-3262. PubMed ID: 28351928
[TBL] [Abstract] [Full Text] [Related]
10. Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial.
Chung V; Mansfield AS; Braiteh F; Richards D; Durivage H; Ungerleider RS; Johnson F; Kovach JS
Clin Cancer Res; 2017 Jul; 23(13):3277-3284. PubMed ID: 28039265
[No Abstract] [Full Text] [Related]
11. PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.
Sai J; Owens P; Novitskiy SV; Hawkins OE; Vilgelm AE; Yang J; Sobolik T; Lavender N; Johnson AC; McClain C; Ayers GD; Kelley MC; Sanders M; Mayer IA; Moses HL; Boothby M; Richmond A
Clin Cancer Res; 2017 Jul; 23(13):3371-3384. PubMed ID: 28003307
[No Abstract] [Full Text] [Related]
12. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
[TBL] [Abstract] [Full Text] [Related]
13. Superficial Ewing's sarcoma family of tumors: a clinicopathological study with differential diagnoses.
Machado I; Llombart B; Calabuig-Fariñas S; Llombart-Bosch A
J Cutan Pathol; 2011 Aug; 38(8):636-43. PubMed ID: 21649689
[TBL] [Abstract] [Full Text] [Related]
14. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.
Sakurai T; Kondoh N; Arai M; Hamada J; Yamada T; Kihara-Negishi F; Izawa T; Ohno H; Yamamoto M; Oikawa T
Cancer Sci; 2007; 98(11):1775-84. PubMed ID: 17727680
[TBL] [Abstract] [Full Text] [Related]
15. From morphological to molecular diagnosis of soft tissue tumors.
Miettinen M
Adv Exp Med Biol; 2006; 587():99-113. PubMed ID: 17163160
[TBL] [Abstract] [Full Text] [Related]
16. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-fli1 in breast and ovarian cancer cell lines.
Meric F; Liao Y; Lee WP; Pollock RE; Hung MC
Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226
[TBL] [Abstract] [Full Text] [Related]
